NO331640B1 - Ekspresjonsvektorer med modifisert Co1E1 replikasjonsorigo og deres anvendelse, vertcelle samt metode for a produsere et protein. - Google Patents

Ekspresjonsvektorer med modifisert Co1E1 replikasjonsorigo og deres anvendelse, vertcelle samt metode for a produsere et protein. Download PDF

Info

Publication number: NO331640B1
Authority: NO; Norway
Prior art keywords: rnaii; rnai; loop; expression vector; vector according
Prior art date: 2000-10-04

Application number

NO20031513A

Other languages

English (en)

Norwegian (no)

Other versions

NO20031513D0 (no

NO20031513L (no

Inventor

Karl Bayer

Reingard Grabherr

Erik Nilsson

Gerald Striedner

Original Assignee

Boehringer Ingelheim Rcv Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-04

Filing date

2003-04-03

Publication date

2012-02-13

2003-04-03 Application filed by Boehringer Ingelheim Rcv Gmbh filed Critical Boehringer Ingelheim Rcv Gmbh

2003-04-03 Publication of NO20031513D0 publication Critical patent/NO20031513D0/no

2003-05-28 Publication of NO20031513L publication Critical patent/NO20031513L/no

2012-02-13 Publication of NO331640B1 publication Critical patent/NO331640B1/no

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 43
230000010076 replication Effects 0.000 title claims abstract description 36
239000013604 expression vector Substances 0.000 title claims abstract description 22
102000004169 proteins and genes Human genes 0.000 title claims description 16
238000000034 method Methods 0.000 title abstract description 19
239000013612 plasmid Substances 0.000 claims abstract description 81
108091030071 RNAI Proteins 0.000 claims abstract description 52
230000035772 mutation Effects 0.000 claims abstract description 39
102000007056 Recombinant Fusion Proteins Human genes 0.000 claims abstract description 26
108010008281 Recombinant Fusion Proteins Proteins 0.000 claims abstract description 26
238000004519 manufacturing process Methods 0.000 claims abstract description 20
239000013598 vector Substances 0.000 claims abstract description 12
108091026890 Coding region Proteins 0.000 claims abstract description 3
108020004566 Transfer RNA Proteins 0.000 claims description 36
230000014509 gene expression Effects 0.000 claims description 27
108020004414 DNA Proteins 0.000 claims description 25
230000001580 bacterial effect Effects 0.000 claims description 14
241000588724 Escherichia coli Species 0.000 claims description 10
230000000295 complement effect Effects 0.000 claims description 8
230000037429 base substitution Effects 0.000 claims description 6
230000009467 reduction Effects 0.000 claims description 2
210000004027 cell Anatomy 0.000 description 21
238000000855 fermentation Methods 0.000 description 12
230000004151 fermentation Effects 0.000 description 12
239000012634 fragment Substances 0.000 description 9
230000002503 metabolic effect Effects 0.000 description 9
239000002773 nucleotide Substances 0.000 description 9
125000003729 nucleotide group Chemical group 0.000 description 9
230000001965 increasing effect Effects 0.000 description 8
230000007246 mechanism Effects 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
150000001413 amino acids Chemical class 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
239000000243 solution Substances 0.000 description 6
230000014616 translation Effects 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
229960000723 ampicillin Drugs 0.000 description 5
239000000872 buffer Substances 0.000 description 5
230000012010 growth Effects 0.000 description 5
230000006698 induction Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
230000008569 process Effects 0.000 description 5
239000002299 complementary DNA Substances 0.000 description 4
239000012153 distilled water Substances 0.000 description 4
239000002609 medium Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
238000012216 screening Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
239000002028 Biomass Substances 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
230000003321 amplification Effects 0.000 description 3
230000027455 binding Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
239000012526 feed medium Substances 0.000 description 3
239000008103 glucose Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
238000011144 upstream manufacturing Methods 0.000 description 3
108020005098 Anticodon Proteins 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
241000272186 Falco columbarius Species 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
102000008221 Superoxide Dismutase-1 Human genes 0.000 description 2
108010021188 Superoxide Dismutase-1 Proteins 0.000 description 2
238000010923 batch production Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
235000003642 hunger Nutrition 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
210000003000 inclusion body Anatomy 0.000 description 2
239000000411 inducer Substances 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
238000005457 optimization Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
230000037351 starvation Effects 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
230000035899 viability Effects 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
101710203526 Integrase Proteins 0.000 description 1
239000006142 Luria-Bertani Agar Substances 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
102100037681 Protein FEV Human genes 0.000 description 1
101710198166 Protein FEV Proteins 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000002518 antifoaming agent Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
244000309466 calf Species 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
238000005251 capillar electrophoresis Methods 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000004637 cellular stress Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000012411 cloning technique Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000013024 dilution buffer Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000010828 elution Methods 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000007412 host metabolism Effects 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000006609 metabolic stress Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000000203 mixture Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
101150078341 rop gene Proteins 0.000 description 1
238000010079 rubber tapping Methods 0.000 description 1
241000894007 species Species 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

Genetics & Genomics (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

NO20031513A 2000-10-04 2003-04-03 Ekspresjonsvektorer med modifisert Co1E1 replikasjonsorigo og deres anvendelse, vertcelle samt metode for a produsere et protein. NO331640B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00121709A EP1195436A1 (fr)	2000-10-04	2000-10-04	Vecteurs d'expression à origine de replication modifiée pour le controle du nombre de copies des plasmides
PCT/EP2001/011240 WO2002029067A1 (fr)	2000-10-04	2001-09-28	Vecteurs d'expression a origine de replication cole1 modifiee utilises dans le controle du nombre de copies de plasmides

Publications (3)

Publication Number	Publication Date
NO20031513D0 NO20031513D0 (no)	2003-04-03
NO20031513L NO20031513L (no)	2003-05-28
NO331640B1 true NO331640B1 (no)	2012-02-13

Family

ID=8170014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031513A NO331640B1 (no)	2000-10-04	2003-04-03	Ekspresjonsvektorer med modifisert Co1E1 replikasjonsorigo og deres anvendelse, vertcelle samt metode for a produsere et protein.

Country Status (18)

Country	Link
US (1)	US6806066B2 (fr)
EP (2)	EP1195436A1 (fr)
JP (2)	JP5405708B2 (fr)
KR (1)	KR100801475B1 (fr)
AT (1)	ATE362987T1 (fr)
AU (1)	AU9188301A (fr)
CA (1)	CA2424624C (fr)
CY (1)	CY1106773T1 (fr)
DE (1)	DE60128580T2 (fr)
DK (1)	DK1326989T3 (fr)
ES (1)	ES2286141T3 (fr)
NO (1)	NO331640B1 (fr)
NZ (1)	NZ525635A (fr)
PT (1)	PT1326989E (fr)
RU (1)	RU2304618C2 (fr)
TW (1)	TWI245798B (fr)
WO (1)	WO2002029067A1 (fr)
ZA (1)	ZA200302080B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI311152B (en)	2004-09-17	2009-06-21	Boehringer Ingelheim Rcv Gmbh & Co K	Host-vector system for antibiotic-free cole1 plasmid propagation
US8999672B2 (en)	2005-01-28	2015-04-07	James A. Williams	Compositions and processes for improved plasmid DNA production
KR101440159B1 (ko) *	2005-09-16	2014-09-15	몬산토 테크놀로지 엘엘씨	이동가능한 혼성 복제개시점 플라스미드
US20090191599A1 (en) *	2007-09-10	2009-07-30	Joule Biotechnologies, Inc.	Engineered light-harvesting organisms
EP2615164A1 (fr) *	2007-11-10	2013-07-17	Joule Unlimited Technologies, Inc.	Organismes hyperphotosynthétiques
US20110269184A1 (en)	2009-07-16	2011-11-03	Boehringer Ingelheim Rcv Gmbh & Co. Kg	Method for controlling plasmid copy number in e.coli
US20130266983A1 (en) *	2010-12-14	2013-10-10	The Regents Of The University Of California	Creation of super-stable ColE1 plasmids by duplication of SL1-4 sequence and point mutations.
CN115885045A (zh)	2020-06-17	2023-03-31	巴斯夫欧洲公司	质粒拷贝数调节和整合
WO2025175381A1 (fr) *	2024-02-22	2025-08-28	Pegasus Biotech Incorporated	Plasmide et procédé de production de vaccins à adn et de produits d'adn
KR20260051065A (ko)	2024-06-05	2026-04-15	와커 헤미 아게	증가된 복제율을 갖는 플라스미드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1209501A (fr) *	1982-09-16	1986-08-12	Nikos Panayotatos	Vecteur d'expression
AU3183289A (en) *	1988-01-27	1989-08-25	Upjohn Company, The	Expression vectors
CA2323604A1 (fr) *	1998-03-19	1999-09-23	Valentis, Inc.	Plasmides d'interferon alpha, systemes d'administration et procedes de fabrication desdits plasmides

2000
- 2000-10-04 EP EP00121709A patent/EP1195436A1/fr not_active Withdrawn
2001
- 2001-09-28 DK DK01972084T patent/DK1326989T3/da active
- 2001-09-28 WO PCT/EP2001/011240 patent/WO2002029067A1/fr not_active Ceased
- 2001-09-28 PT PT01972084T patent/PT1326989E/pt unknown
- 2001-09-28 KR KR1020037004057A patent/KR100801475B1/ko not_active Expired - Fee Related
- 2001-09-28 JP JP2002532636A patent/JP5405708B2/ja not_active Expired - Fee Related
- 2001-09-28 AU AU9188301A patent/AU9188301A/xx active Pending
- 2001-09-28 EP EP01972084A patent/EP1326989B1/fr not_active Expired - Lifetime
- 2001-09-28 RU RU2003112609/13A patent/RU2304618C2/ru not_active IP Right Cessation
- 2001-09-28 ES ES01972084T patent/ES2286141T3/es not_active Expired - Lifetime
- 2001-09-28 NZ NZ525635A patent/NZ525635A/xx not_active IP Right Cessation
- 2001-09-28 DE DE60128580T patent/DE60128580T2/de not_active Expired - Lifetime
- 2001-09-28 CA CA002424624A patent/CA2424624C/fr not_active Expired - Fee Related
- 2001-09-28 AT AT01972084T patent/ATE362987T1/de active
- 2001-10-03 US US09/969,136 patent/US6806066B2/en not_active Expired - Lifetime
- 2001-10-05 TW TW090124670A patent/TWI245798B/zh not_active IP Right Cessation
2003
- 2003-03-14 ZA ZA200302080A patent/ZA200302080B/en unknown
- 2003-04-03 NO NO20031513A patent/NO331640B1/no not_active IP Right Cessation
2007
- 2007-07-30 CY CY20071101010T patent/CY1106773T1/el unknown
2013
- 2013-09-30 JP JP2013203972A patent/JP2014012023A/ja active Pending

Also Published As

Publication number	Publication date
EP1195436A1 (fr)	2002-04-10
NO20031513D0 (no)	2003-04-03
KR100801475B1 (ko)	2008-02-12
WO2002029067A1 (fr)	2002-04-11
EP1326989B1 (fr)	2007-05-23
JP2014012023A (ja)	2014-01-23
TWI245798B (en)	2005-12-21
DE60128580T2 (de)	2007-09-13
CY1106773T1 (el)	2012-01-25
ES2286141T3 (es)	2007-12-01
NO20031513L (no)	2003-05-28
RU2304618C2 (ru)	2007-08-20
DK1326989T3 (da)	2007-09-10
AU2001291883C1 (en)	2002-04-15
ZA200302080B (en)	2004-05-05
EP1326989A1 (fr)	2003-07-16
JP5405708B2 (ja)	2014-02-05
NZ525635A (en)	2004-12-24
JP2004510437A (ja)	2004-04-08
CA2424624C (fr)	2008-11-18
CA2424624A1 (fr)	2002-04-11
KR20030074598A (ko)	2003-09-19
DE60128580D1 (de)	2007-07-05
US20030166053A1 (en)	2003-09-04
ATE362987T1 (de)	2007-06-15
AU9188301A (en)	2002-04-15
US6806066B2 (en)	2004-10-19
PT1326989E (pt)	2007-06-08

Legal Events

Date	Code	Title	Description
2017-04-24	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
JP2014012023A (ja)	2014-01-23	改変されたＣｏｌＥ１の複製開始点を有する、プラスミドコピー数の制御のための発現ベクター
KR100760222B1 (ko)	2007-10-04	유전자 증폭에 의해 증가된 리신 생산
CN102690808B (zh)	2017-04-19	为真核表达的目的构建原核基因表达岛
Sakamoto et al.	2008	Aspergillus oryzae atfB encodes a transcription factor required for stress tolerance in conidia
NZ553945A (en)	2010-03-26	Process for plasmid DNA fermentation
Narberhaus et al.	1996	The Bradyrhizobium japonicum rpoH1 gene encoding a sigma 32-like protein is part of a unique heat shock gene cluster together with groESL1 and three small heat shock genes
CN114686990A (zh)	2022-07-01	一种启动子文库及其制备方法和应用
JP2023548278A (ja)	2023-11-16	改善特性を有する遺伝子改変メチロバチルス細菌
CN109136253B (zh)	2021-08-10	一种通过糖多孢红霉菌sace_5754基因途径提高红霉素产量的方法
Tyo et al.	2011	Directed evolution of promoters and tandem gene arrays for customizing RNA synthesis rates and regulation
CN104830860A (zh)	2015-08-12	一种可以提高植物基因表达活性的间隔重复序列及应用
AU2001291883B2 (en)	2007-03-08	Expression vectors with modified ColE1 origin of replication for control of plasmid copy number
Murugan et al.	2021	RNAi-based gene silencing in sugarcane for production of biofuel
CN114774421B (zh)	2023-04-28	运动发酵单胞菌内源性启动子突变体
AU2001291883A1 (en)	2002-06-27	Expression vectors with modified ColE1 origin of replication for control of plasmid copy number
Chen et al.	2009	DnaJ-like protein gene sll1384 is involved in phototaxis in Synechocystis sp. PCC 6803
CN101724646B (zh)	2012-07-18	利用调控蛋白基因提高阿维菌素的产量
CN109694869B (zh)	2022-07-12	一种大豆圣豆9号GmPK6基因盐诱导启动子及其应用
JP4142649B2 (ja)	2008-09-03	プラスミドのレベルの変更方法
CN118652919A (zh)	2024-09-17	提高桃色欧文氏菌安吉菌素产量的方法
JP3682530B2 (ja)	2005-08-10	酵母の形質転換方法
Long et al.	2011	Effects of different light treatments on the natural transformation of Synechocystis sp. strain PCC 6803
WO2006002574A1 (fr)	2006-01-12	Vecteur de plasmide regule par le facteur sigma 32 de escherichia coli et son utilisation dans l'expression d'une proteine heterologue
Herrington et al.	2002	A mutation in the folA promoter delays adaptation to minimal medium by Escherichia coli K‐12
CN119639767A (zh)	2025-03-18	水稻转录因子OsMYB5及其在调控花色苷合成中的应用